0000947871-23-000751.txt : 20230713
0000947871-23-000751.hdr.sgml : 20230713
20230713200938
ACCESSION NUMBER: 0000947871-23-000751
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230713
DATE AS OF CHANGE: 20230713
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Galecto, Inc.
CENTRAL INDEX KEY: 0001800315
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371957007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39655
FILM NUMBER: 231087773
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 45-70-70-52-10
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Galecto Inc.
DATE OF NAME CHANGE: 20200116
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: OrbiMed Advisors Israel II Ltd
CENTRAL INDEX KEY: 0001682093
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
144
1
primary_doc.xml
144
0001682093
XXXXXXXX
LIVE
0001800315
Galecto, Inc.
001-39655
75 State Street
Suite 100
Boston
MA
02109
45-70-70-52-10
OrbiMed Israel Partners II, L.P.
Shareholder
Common Stock
Bank of America
One Bryant Park
New York
NY
10036
52800
134640.00
25673474
07/13/2023
Nasdaq Stock Market
Common Stock
10/23/2018
Private placement
Issuer
N
52800
10/23/2018
Cash
N
OrbiMed Israel Partners II, L.P.
5 Hahoshlim St.
Building B, 1st Floor
Herzliya Pituach
L3
4614001
Common Stock
04/14/2023
11245
20915.70
OrbiMed Israel GP II, L.P. is the general partner of OrbiMed Israel Partners II, L.P. OrbiMed Advisors Israel II Limited is the general partner of OrbiMed Israel GP II, L.P. OrbiMed Israel Partners II, L.P. sold 3,551 shares of Common Stock on April 17, 2023 at a per share price of $1.97 for gross proceeds of $6,995.47.
07/13/2023
/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors II Limited, general partner of the general partner of OrbiMed Israel Partners II, L.P.